What is Codoxo?
Codoxo provides a comprehensive, Generative AI-powered Unified Cost Containment Platform designed specifically for healthcare payers. The platform addresses the critical challenges of payment integrity, fraud, waste, and abuse (FWA) by intervening at the earliest possible point in the claim lifecycle. By integrating capabilities such as clinical chart review, data mining, and provider contract compliance, Codoxo enables payers to achieve superior accuracy and operational efficiency. The company's market position is bolstered by its ability to reduce administrative overhead while simultaneously improving provider relationships, a dual-value proposition that has earned it significant industry recognition, including the Fierce Healthcare Innovation Award.
How much funding has Codoxo raised?
Codoxo has raised a total of $63.5M across 4 funding rounds:
Angel/Seed
$1.5M
Series A
$7M
Series B
$20M
Series C
$35M
Angel/Seed (2017): $1.5M with participation from Mosley Ventures, Spider Capital, TechSquare Labs, and GRA Venture Fund
Series A (2020): $7M led by GRA Venture Fund, Brewer Lane Ventures, and QED Investors
Series B (2022): $20M supported by Spider Capital, 111 West Capital, Brewer Lane Ventures, QED Investors, GRA Venture Fund, and Sands Capital
Series C (2025): $35M featuring Brewer Lane Ventures, 111° West Capital, Sands Capital, and Echo Health Ventures
Key Investors in Codoxo
Brewer Lane Ventures
Brewer Lane Ventures is an investment firm focused on supporting exceptional entrepreneurs in the financial and healthcare technology sectors, providing strategic advice to help founders build market-leading companies.
111° West Capital
111° West Capital is a healthcare-focused investment firm that partners with enterprise software companies transforming the healthcare sector through a hands-on, multi-stage investment approach.
Sands Capital
Established in 1992, Sands Capital Management is a prominent investment firm that manages equity mutual funds and invests in public equity markets with a focus on long-term growth.
What's next for Codoxo?
With the infusion of $35M, Codoxo is well-positioned to scale its enterprise operations and deepen its technological capabilities. The company's strategic roadmap likely involves expanding its AI-native feature set to address emerging complexities in medical policy compliance and automated audit workflows. As the healthcare sector continues to prioritize cost containment and digital transformation, Codoxo's ability to prevent payment errors before they occur will remain a critical asset. The firm is expected to leverage its strong backing from specialized healthcare and enterprise-focused investors to solidify its leadership in the payment integrity market and drive long-term, sustainable growth across the national payer landscape.
See full Codoxo company page
